Al18F-NOTA-FAPI-04 PET/CT 揭示黏膜相关淋巴组织淋巴瘤肝脏病灶
Hepatic Lesion of Mucosa-Associated Lymphoid Tissue Lymphoma Revealed by Al18F-NOTA-FAPI-04 PET/CT.
PubMed 文献 · Clin Nucl Med · 2022-01-01
一例中年男性新诊断黏膜相关淋巴组织淋巴瘤伴继发性肝脏受累,FDG PET/CT 未显示肝脏病灶,而 FAPI PET/CT 显示异常 FAPI 摄取。该病例提示 FAPI PET/CT 可能对肝脏黏膜相关淋巴组织淋巴瘤具有价值。
要点
- FDG PET/CT 未显示肝脏病灶,FAPI PET/CT 显示异常 FAPI 摄取。
- FAPI PET/CT 可能对肝脏黏膜相关淋巴组织淋巴瘤提供价值。
核心结论
- FAPI PET/CT 可能对肝脏黏膜相关淋巴组织淋巴瘤具有价值。
研究设计与样本
- 本文为单个病例报告,描述一名中年男性新诊断黏膜相关淋巴组织淋巴瘤伴继发性肝脏受累的影像学表现。
主要发现
- FDG PET/CT 未显示肝脏病灶,而 FAPI PET/CT 显示异常 FAPI 积累。
临床怎么用
- 在 FDG PET/CT 阴性的黏膜相关淋巴组织淋巴瘤肝脏受累评估中,可考虑 FAPI PET/CT 作为补充影像手段。
局限性
- 本文为单病例报告,结论基于个别观察,需更多研究验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
A middle-aged man was newly diagnosed with mucosa-associated lymphoid tissue lymphoma with secondary liver involvement. The hepatic lesion was not shown on FDG PET/CT but FAPI (fibroblast-activated protein inhibitor) PET/CT, which revealed abnormal FAPI accumulation. This case demonstrated that FAPI PET/CT might provide value in hepatic mucosa-associated lymphoid tissue lymphoma.
来源:Clin Nucl Med,查看原文。版权归原作者所有。
引用
- Kou Y, Yao Z, Cheng Z, et al. Hepatic Lesion of Mucosa-Associated Lymphoid Tissue Lymphoma Revealed by Al18F-NOTA-FAPI-04 PET/CT. Clin Nucl Med. 2022. PMID: 34392285. doi:10.1097/RLU.0000000000003863
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。